Chester County News and Community Website
WASHINGTON, D.C. — The Food and Drug Administration rolled out a rapid-fire series of moves this month that could reshape how Americans manage chronic disease, treat rare and life-threatening blood …
FDA’s Week of Breakthroughs: New Gene Therapy, New Antibiotics, New Rules Read More
WASHINGTON, D.C. — The United States and the United Kingdom reached a sweeping agreement in principle last week to rebalance pharmaceutical pricing between the two nations, marking a rare international …
U.S. Strikes Breakthrough Drug-Pricing Deal With U.K., Promising Major Shift in Global Pharma Costs Read More
WASHINGTON, D.C. — The federal government is quietly preparing one of the most sweeping overhauls of Medicare policy in years, advancing a slate of proposed and final rules that could …
Medicare Shake-Up: Inside CMS’s Sweeping Plan To Rewrite The Rules For Seniors Read More
HARRISBURG, PA — A bill designed to prevent thousands of older Pennsylvanians from losing access to affordable prescription medications is on its way to becoming law, following bipartisan approval in …
New Push to Protect Seniors’ Prescription Benefits Sparks Big Policy Shift Read More
WASHINGTON, D.C. — The longstanding Medicaid financing system is undergoing its most sweeping overhaul in decades as the Centers for Medicare & Medicaid Services on Friday issued new federal guidance …
New CMS Rules Shake Up Medicaid Financing as Medicare Costs Climb for 2026 Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration announced a sweeping set of reforms and enforcement actions last week aimed at lowering prescription drug costs and protecting children from …
FDA Cracks Down on Unapproved Fluoride Drugs, Fast-Tracks Cheaper Biologic Alternatives Read More
WASHINGTON, D.C. — President Donald J. Trump on Friday announced a new agreement with pharmaceutical company AstraZeneca aimed at lowering prescription drug costs and strengthening U.S. manufacturing, part of a …
Trump Administration, AstraZeneca Reach Deal to Cut Drug Prices and Expand U.S. Investment Read More
WASHINGTON, D.C. — Average premiums for Medicare Advantage and Medicare Part D prescription drug plans are expected to decline in 2026, the Centers for Medicare & Medicaid Services (CMS) announced …
Medicare Premiums To Decline in 2026, Open Enrollment Approaches Read More
WASHINGTON, D.C. — The Centers for Disease Control and Prevention issued a series of public health updates last week, reporting a steep rise in dangerous drug-resistant bacteria, troubling increases in …
CDC Warns of Drug-Resistant Bacteria Surge, Rising Syphilis in Newborns, and Listeria Outbreak Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) announced a series of actions last week aimed at strengthening consumer protections, advancing rare disease treatment development, and improving drug …
FDA Issues Series of Regulatory Actions Targeting Public Health, Transparency, and Drug Safety Read More